info@bblsa.com   +1.617.236.0954
Graph - 2015 Number of Companies and Dollars Raised – Life Sciences Private Financings

Back Bay in Pharmaceutical Executive: The State of Cross-Border Funding in the Life Sciences

A new article by Back Bay Senior Associate and life science transaction advisory expert, James Leech, brings insight to cross-border funding in the life sciences.

In the current issue of Pharmaceutical Executive, The State of Cross-Border Funding in the Life Sciences describes record capital flow across global markets that have opened new channels of investment in early-stage and novel science. While the U.S. remains fertile ground for investable life science opportunities and continues to be a target capital source for emerging companies, Mr. Leech writes:  (more…)

Share this:
back bay life science advisors logo

Mentoring the Next Generation of Life Science Innovators

By Jonathan P. Gertler, MD

In the life science community, it’s necessary to return to our academic roots to foster knowledge, share learning, and cultivate the careers of those coming up the ranks. Dedicating time to mentoring the next generation of innovators and entrepreneurs is not an optional activity: the life sciences rely on the “new guard” for our future breakthrough treatment, medical technology, or a new way to approach age-old problems.

(more…)

Share this:
Amazon and PillPack: a threat to the pharmacy model or business as usual?

Amazon and PillPack: a threat to the pharmacy model or business as usual?

/ Transaction News
By James Leech, Senior Associate, Back Bay Life Science Advisors

On Friday, June 29 Amazon announced that it would be acquiring its first online pharmacy retailer, PillPack for $1 billion in cash. With around $100 million in revenue last year, the acquisition price implies a 9x – 10x revenue multiple for the Company. PillPack’s latest $30 million private financing round was raised at a $330 million pre-money valuation, with this acquisition resulting in a respectable return for the company’s venture investor syndicate.

(more…)

Share this:
Princeton University Logo

Princeton University Graduate Consulting Club Case Competition

Event date: June 22, 2018

Back Bay Senior Consultant, Tejdeep Singh Bawa has been invited for the second year to mentor, judge, and guide members of Princeton’s University Graduate Consulting Club through the 2018 PuGCC Case Competition.

On June 22, 2018 twenty-four teams of graduate and professional students interested in management consulting will show their expertise and creative thinking and learn high-level consulting skills from seasoned experts in the field, including Back Bay Life Science Advisors, McKinsey & Company, Accenture, and Boston Consulting Group.
(more…)

Share this:
2018 ASCO Annual Meeting

Back Bay at Annual meeting of the American Society of Clinical Oncology (ASCO)

/ ASCO, Cancer, Oncology

Event date: June 1-5, 2018

Back Bay joined the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, where thousands of oncology professionals from around the world gathered to share the latest approaches to cancer care.
(more…)

Share this:
BIO2018 Banner

Back Bay Welcomes the BIO International Convention to Boston

Event date: June 4-7, 2018

The Back Bay team, led by Chris Leo, Greg Benning, and Vasilios M. Kofitsas welcomed the 2018 Bio International Convention to our hometown of Boston. Boston’s trajectory as a biotech leader has been remarkable, and we’re proud to be part of the biotech and med tech evolution here. BIO brings together thousands from biopharma, med tech and more for collaborative discussion, networking and partnering opportunities.

(more…)

Share this:
Immunotherapies white paper

Back Bay Report on Neoantigen-Based Cancer Immunotherapy

By Jonathan P. Gertler, MD

Immuno-oncology, a promise for decades, has burst forth as a clear means to advance patient care and spur research and development. Science and industry are working fervently to untangle this data-heavy, rapidly-evolving field and bring effective IO combinations to more patients. As positive data and widespread support accumulate for the potential checkpoint inhibitors and neoantigens in numerous challenging and refractory cancers, hundreds of trials are being implemented that seek to increase efficacy and bring these novel therapeutics to more patients in critical need.

(more…)

Share this:
back bay life science advisors logo

Asia Opens Its Doors for Pre-Revenue Biotechs

/ Biotech
By Ned Benning, Analyst, Back Bay Life Science Advisors

One of the primary axioms at Back Bay Life Science Advisors is that assets must find the right form of capital. Venture is not right for every academic-derived technology. Going public is not right for every growing company or late-stage biotech. Geographic variation can bring different timelines, different IRR hurdles, and different ecosystem mandates. Capital sources are forever shifting, and lately, investment from China has been looming large on the radar screen for U.S. biotech. We see this as a good thing. (more…)

Share this:
Transcatheter Mitral Valve Technologies: The Heart of Cardiovascular Device Innovation

Transcatheter Mitral Valve Technologies: The Heart of Cardiovascular Device Innovation

By Tejdeep Singh Bawa, Michelle Hoffmann, Susan Thompson, Stephanie Kwei

Medical device companies developing next-generation mitral valve repair and replacement technologies have generated unprecedentedly high valuations at ever-earlier stages of device development. Medtech investors are acquiring early-stage transcatheter mitral valve technologies long before commercialization and even before critical clinical data is amassed.

(more…)

Share this:
BIO2018 Banner

Back Bay CEO Selected as Judge for BIO 2018 Start-Up Stadium

RE: Jonathan P. Gertler

Boston, May 1, 2018—Back Bay Life Science Advisors, strategic and transactional advisors to the life science industry, announced today that Jonathan P. Gertler, Managing Partner and CEO, has been selected to judge the Start-up Stadium competition at the upcoming BIO International Convention (BIO 2018) June 4-7 in Boston.

(more…)

Share this:
Loading...
Share this: